128 related articles for article (PubMed ID: 37702453)
1. Pilocarpine HCl 1.25% for treatment of presbyopia after laser vision correction: pooled analysis of two phase 3 randomized trials (GEMINI 1 and 2).
Lievens CW; Hom MM; McLaurin EB; Yuan J; Safyan E; Liu H
J Cataract Refract Surg; 2024 Jan; 50(1):57-63. PubMed ID: 37702453
[TBL] [Abstract][Full Text] [Related]
2. Wavefront excimer laser refractive surgery for adults with refractive errors.
Li SM; Kang MT; Wang NL; Abariga SA
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012687. PubMed ID: 33336797
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Twice-Daily Pilocarpine HCl in Presbyopia: The Virgo Phase 3, Randomized, Double-Masked, Controlled Study.
Kannarr S; El-Harazi SM; Moshirfar M; Lievens C; Kim JL; Peace JH; Safyan E; Liu H; Zheng S; Robinson MR
Am J Ophthalmol; 2023 Sep; 253():189-200. PubMed ID: 37149245
[TBL] [Abstract][Full Text] [Related]
4. Spherical and aspherical photorefractive keratectomy and laser in-situ keratomileusis for moderate to high myopia: two prospective, randomized clinical trials. Summit technology PRK-LASIK study group.
Steinert RF; Hersh PS
Trans Am Ophthalmol Soc; 1998; 96():197-221; discussion 221-7. PubMed ID: 10360290
[TBL] [Abstract][Full Text] [Related]
5. Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. A randomized prospective study.
Hersh PS; Brint SF; Maloney RK; Durrie DS; Gordon M; Michelson MA; Thompson VM; Berkeley RB; Schein OD; Steinert RF
Ophthalmology; 1998 Aug; 105(8):1512-22, discussion 1522-3. PubMed ID: 9709767
[TBL] [Abstract][Full Text] [Related]
6. Quality of Vision Following LASIK and PRK-MMC for Treatment of Myopia.
Gao H; Miles TP; Troche R; Murdoch DM; Koefoed VF; Cason JB
Mil Med; 2022 Aug; 187(9-10):e1051-e1058. PubMed ID: 33629728
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of AGN-190584 in Individuals With Presbyopia: The GEMINI 1 Phase 3 Randomized Clinical Trial.
Waring GO; Price FW; Wirta D; McCabe C; Moshirfar M; Guo Q; Gore A; Liu H; Safyan E; Robinson MR
JAMA Ophthalmol; 2022 Apr; 140(4):363-371. PubMed ID: 35238902
[TBL] [Abstract][Full Text] [Related]
8. Comparison of laser in situ keratomileusis and photorefractive keratectomy for the correction of myopia of -6.00 diopters or less. Melbourne Excimer Laser Group.
Tole DM; McCarty DJ; Couper T; Taylor HR
J Refract Surg; 2001; 17(1):46-54. PubMed ID: 11201777
[TBL] [Abstract][Full Text] [Related]
9. Randomized bilateral comparison of excimer laser in situ keratomileusis and photorefractive keratectomy for 2.50 to 8.00 diopters of myopia.
El-Maghraby A; Salah T; Waring GO; Klyce S; Ibrahim O
Ophthalmology; 1999 Mar; 106(3):447-57. PubMed ID: 10080199
[TBL] [Abstract][Full Text] [Related]
10. Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia.
Shortt AJ; Allan BD; Evans JR
Cochrane Database Syst Rev; 2013 Jan; (1):CD005135. PubMed ID: 23440799
[TBL] [Abstract][Full Text] [Related]
11. Femtosecond laser assisted in situ keratomileusis (FS-LASIK) yields better results than transepithelial photorefractive keratectomy (Trans-PRK) for correction of low to moderate grade myopia.
Gershoni A; Reitblat O; Mimouni M; Livny E; Nahum Y; Bahar I
Eur J Ophthalmol; 2021 Nov; 31(6):2914-2922. PubMed ID: 33307790
[TBL] [Abstract][Full Text] [Related]
12. Myopia correction with transepithelial photorefractive keratectomy versus femtosecond-assisted laser in situ keratomileusis: One-year case-matched analysis.
Luger MH; Ewering T; Arba-Mosquera S
J Cataract Refract Surg; 2016 Nov; 42(11):1579-1587. PubMed ID: 27956284
[TBL] [Abstract][Full Text] [Related]
13. 200 Hz flying-spot technology of the LaserSight LSX excimer laser in the treatment of myopic astigmatism: six and 12 month outcomes of laser in situ keratomileusis and photorefractive keratectomy.
Stojanovic A; Nitter TA
J Cataract Refract Surg; 2001 Aug; 27(8):1263-77. PubMed ID: 11524200
[TBL] [Abstract][Full Text] [Related]
14. Comparison of photorefractive keratectomy with excimer laser in situ keratomileusis in correcting low myopia (from -2.00 to -5.50 diopters). A randomized study.
el Danasoury MA; el Maghraby A; Klyce SD; Mehrez K
Ophthalmology; 1999 Feb; 106(2):411-20; discussion 420-1. PubMed ID: 9951500
[TBL] [Abstract][Full Text] [Related]
15. Optical quality after myopic photorefractive keratectomy and laser in situ keratomileusis: comparison using a double-pass system.
Ondategui JC; Vilaseca M; Arjona M; Montasell A; Cardona G; Güell JL; Pujol J
J Cataract Refract Surg; 2012 Jan; 38(1):16-27. PubMed ID: 22153091
[TBL] [Abstract][Full Text] [Related]
16. Photorefractive keratectomy (PRK) versus laser-assisted in-situ keratomileusis (LASIK) for myopia.
Shortt AJ; Allan BD
Cochrane Database Syst Rev; 2006 Apr; (2):CD005135. PubMed ID: 16625626
[TBL] [Abstract][Full Text] [Related]
17. Topical cyclosporine A for postoperative photorefractive keratectomy and laser in situ keratomileusis.
Hessert D; Tanzer D; Brunstetter T; Kaupp S; Murdoch D; Mirzaoff M
J Cataract Refract Surg; 2013 Apr; 39(4):539-47. PubMed ID: 23415779
[TBL] [Abstract][Full Text] [Related]
18. Wavefront-guided laser in situ keratomileusis (Lasik) versus wavefront-guided photorefractive keratectomy (Prk): a prospective randomized eye-to-eye comparison (an American Ophthalmological Society thesis).
Manche EE; Haw WW
Trans Am Ophthalmol Soc; 2011 Dec; 109():201-20. PubMed ID: 22253488
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two procedures: photorefractive keratectomy versus laser in situ keratomileusis for low to moderate myopia.
Lee JB; Kim JS; Choe C; Seong GJ; Kim EK
Jpn J Ophthalmol; 2001; 45(5):487-91. PubMed ID: 11583670
[TBL] [Abstract][Full Text] [Related]
20. Visual outcomes after Epi-LASIK and PRK for low and moderate myopia.
Sia RK; Coe CD; Edwards JD; Ryan DS; Bower KS
J Refract Surg; 2012 Jan; 28(1):65-71. PubMed ID: 21985667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
